Sandra Müller

Company: Molecular Partners AG

Job title: Scientist Oncology Research

Seminars:

Application of the DARPin® Technology for Specific Targeting of Peptide: MHC Complexes 1:00 pm

Discussing DARPin® proteins that represent a compelling alternative to specifically target peptide MHC complexes: They are highly potent and specific Favorable properties of the DARPin® proteins enable fast and straight forward manufacturing, facilitating the developabilityRead more

day: Day One